ScreenerHero
SBRASabra Health Care REIT, Inc.
NAS · US · Real Estate · REIT - Healthcare Facilities · sabrahealth.com
19.51USD-0.05%Mkt Cap: 4.92B $P/E: 30.97

Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the Unite…

Industry Peers

REIT - Healthcare Facilities
Screen all
vs REIT - Healthcare Facilities
P/E
Avg
P/B
Avg
Div Yield
Avg
1M Perf
Higher
WELL
Welltower Inc.
$160.22BUSDP/E 109.6
VTR
Ventas, Inc.
$43.17BUSDP/E 161.5
OHI
Omega Healthcare Investors, Inc.
$14.87BUSDP/E 23.0
DOC
Healthpeak Properties, Inc.
$14.75BUSDP/E 66.9
CTRE
CareTrust REIT, Inc.
$9.53BUSDP/E 25.5
HR
Healthcare Realty Trust Incorporated
$7.07BUSD
AED
Aedifica NV/SA
$6.41BUSDP/E 6.1
CSH-UN
Chartwell Retirement Residences
$5.30BUSDP/E Infinity
NHI
National Health Investors, Inc.
$3.70BUSDP/E 24.6
COFB
Cofinimmo SA
$3.43BUSDP/E 15.5
PHP
Primary Health Properties Plc
$2.70BUSDP/E 13.7
MPT
Medical Properties Trust, Inc.
$2.76BUSD
DHC
Diversified Healthcare Trust
$2.25BUSD
LTC
LTC Properties, Inc.
$1.97BUSDP/E 15.1
SILA
Sila Realty Trust, Inc.
$1.68BUSDP/E 44.6
NHP
National Healthcare Properties, Inc.
$1.08BUSD
CPINV
Care Property Invest NV
$578.96MUSDP/E 8.3
UHT
Universal Health Realty Income Trust
$608.58MUSDP/E 34.3
CHCT
Community Healthcare Trust Incorporated
$522.29MUSDP/E 152.3
XRN
Chiron Real Estate Inc.
$496.57MUSD
STRW
Strawberry Fields REIT, Inc.
$184.62MUSDP/E 21.5
Indicators:|

Key Statistics

Company
Market Cap4.92B $
Enterprise Value7.47B $
Revenue (TTM)815.66M $
Gross Profit503.53M $
Net Income (TTM)155.61M $
Revenue/Share3.331 USD
Last Price19.51 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees58
CountryUS
SectorReal Estate
IndustryREIT - Healthcare Facilities
ISINUS78573L1061
Valuation
P/E (Trailing)30.97
P/E (Forward)26.25
PEG5.28
EV/EBITDA16.27
EV/Revenue9.16
P/S6.03
P/B1.77
EPS (TTM)0.63
EPS (Forward)0.74
52W Range
17.1757% of range21.28
52W High21.28 USD
52W Low17.17 USD
Profitability
Gross Margin65.00%
Oper. Margin31.41%
EBITDA Margin56.30%
Profit Margin20.09%
ROE5.51%
ROA2.83%
Growth
Revenue Growth21.70%
Earnings Growth-5.60%
Cash Flow & Leverage
Operating CF348.61M $
CapEx (TTM)—
FCF Margin24.25%
FCF Yield4.02%
Net Debt2.55B $
Net Debt/EBITDA5.55
Balance Sheet
Debt/Equity0.90
Current Ratio2.62
Quick Ratio1.99
Book Value/Sh11.05 USD
Cash/Share0.4920 USD
Dividends
Fwd Div Rate1.200 USD
Trail. Div Rate1.200 USD
Div. Yield6.15%
5Y Avg Yield7.93%
Payout Ratio190.48%
Ex-Div DateMay 15, 2026
Pay DateMay 29, 2026
Splits
Last Split1:3
Split DateNov 16, 2010
Analyst Consensus
Rating2.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)22.15 USD
Upside (mean)+13.6%
Target Range19.00 USD – 25.00 USD
$19.00+13.6% to mean$25.00
# Analysts13
Ownership
Shares Out.252.19M
Float247.96M
Insiders1.41%
Institutions108.10%
Short Interest
Short Ratio9.4d
Short % Float14.50%
Short % Out.10.53%
Shares Short26.55M
Short (prev mo.)31.37M
Technical
SMA 5019.78 (-1.3%)
SMA 20019.31 (+1.1%)
Beta0.63
S&P 52W Chg20.05%
Avg Vol (30d)2.78M
Avg Vol (10d)4.33M
Technical Indicators
RSI (14)54.9
MACD-0.1149
MACD Signal-0.3122
MACD Hist.+0.1973
BB Upper19.73 USD
BB Middle18.66 USD
BB Lower17.60 USD
BB Width11.42%
ATR (14)0.5054 USD
Vol Ratio (20d)0.77x